MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-13-2026
STAAR Surgical Company Cash Conversion Cycle 2011-2026 | STAA
Annual Cash Conversion Cycle STAAR Surgical Company
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 | 26 | 23.2 | 20.1 | 0.04 | 166 | - | 196 | 192 | 219 | 184 | 160 | - | 174 | 173 | 62.7 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 219 | 0.04 | 114 |
Quarterly Cash Conversion Cycle STAAR Surgical Company
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -12.7 | -17.7 | 38.1 | - | 25.5 | -5.92 | 9.77 | - | 62.1 | 34.6 | 19.1 | - | 11.6 | -7.39 | -7.01 | 66.1 | 12.5 | 6.85 | -4.23 | 85.7 | 16.5 | 17.9 | 3.12 | - | 3.19 | -2.11 | 0.05 | 75.9 | -0.74 | 1.23 | -1.01 | 69.6 | -5.23 | -1.85 | 92.5 | 66 | -72 | -48.4 | 70.6 | 65.6 | 201 | 200 | 180 | 53.9 | 199 | 178 | 80.4 | - | 185 | 168 | 162 | 47.3 | 176 | 171 | 183 | 50.6 | 181 | 164 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 201 | -72 | 61.3 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
210 | $ 60.38 | - | $ 12 B |  USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Repro Med Systems
KRMD
|
83.1 | $ 3.98 | - | $ 184 M | USA |
 |
ICU Medical
ICUI
|
146 | $ 122.99 | 0.78 % | $ 3.03 B | USA |
 |
iRhythm Technologies
IRTC
|
59.8 | $ 114.16 | - | $ 3.65 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
203 | $ 428.06 | - | $ 153 B | USA |
 |
Alcon
ALC
|
134 | $ 64.0 | -0.03 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
29 | $ 99.5 | - | $ 2.25 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 178.35 | - | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
404 | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
77.3 | $ 23.86 | - | $ 4.01 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
-39.3 | $ 6.43 | - | $ 54.5 K | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 57.12 | - | $ 2.87 B | USA |
 |
Isoray
ISR
|
353 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 142.15 | - | $ 6.88 B | USA |
 |
STERIS plc
STE
|
112 | $ 215.98 | - | $ 21.3 B | USA |
 |
Teleflex Incorporated
TFX
|
285 | $ 130.28 | - | $ 5.81 B | USA |
 |
InfuSystem Holdings
INFU
|
30.8 | $ 8.61 | - | $ 178 M | USA |
 |
Microbot Medical
MBOT
|
-34.9 | $ 1.85 | - | $ 84.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
543 | $ 0.34 | -0.87 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
167 | $ 62.56 | - | $ 3.7 B | USA |
 |
Utah Medical Products
UTMD
|
321 | $ 63.7 | - | $ 206 M | USA |
 |
West Pharmaceutical Services
WST
|
97.3 | $ 300.19 | - | $ 21.7 B | USA |
 |
Pulse Biosciences
PLSE
|
-1.32 K | $ 27.1 | - | $ 1.83 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
66 | $ 10.41 | - | $ 2.08 B | USA |
 |
Retractable Technologies
RVP
|
203 | $ 0.69 | 0.01 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
193 | $ 58.65 | - | $ 193 M | USA |
 |
Predictive Oncology
POAI
|
-7.15 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
322 | $ 21.06 | - | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
143 | $ 1.94 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
106 | $ 17.78 | - | $ 9.12 B | USA |
 |
ResMed
RMD
|
167 | $ 202.46 | - | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
185 | $ 28.15 | - | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
243 | $ 5.52 | - | $ 245 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
124 | $ 11.03 | - | $ 451 M | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 144.47 | - | $ 41.6 B | USA |
 |
Nephros
NEPH
|
150 | $ 3.34 | - | $ 35.4 M | USA |
 |
OraSure Technologies
OSUR
|
211 | $ 2.95 | - | $ 217 M | USA |
 |
Repligen Corporation
RGEN
|
203 | $ 103.38 | - | $ 5.81 M | USA |